Amuthavalli Ath Merc John Sundarraj, NP
Nurse Practitioner · Los Gatos
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 3
Offices
3 locations · Sutter Bay Medical Foundation · 3,783 clinicians in this group
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Amuthavalli Ath Merc John Sundarraj’s office to ask if they take your plan before you enroll.
Original Medicare doctor bills
$20,174
Medicare paid this office $20,174 for 166 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 92 | $10,672 | $98 |
| New patient visit (45+ min) | 39 | $4,592 | $118 |
| Short return visit (20+ min) | 35 | $2,247 | $64 |
Who their Medicare patients are
166 Original Medicare patients in 2024. Average age 77 · Women 57% · Also on Medicaid 9% · Health risk score 0.96. At or below the middle of the specialty; the typical nurse practitioner clinician is at 1.42.
Conditions among them: High blood pressure 71% · Diabetes 24% · Coronary heart disease 20% · Chronic kidney disease 20% · Depression 20% · Cancer 16% · Atrial fibrillation 16% · Heart failure 11% · COPD 8% · Stroke 8%.
The office billed $80,865, Medicare allowed $27,408 and paid $20,174; for 204 services of 13 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Drugs they prescribed that Part D paid
$29,132
Pharmacies billed $29,132 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
371 generic and fewer than 11 brand-name prescriptions · $29,132 in drug cost · 32 antibiotic prescriptions to 26 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Paxlovid | 11 | $1,429 | $130 |
| Albuterol Sulfate Hfa | 14 | $468 | $33 |
| Levothyroxine | 25 | $332 | $13 |
| Losartan | 25 | $263 | $11 |
| Atorvastatin | 16 | $250 | $16 |
See all 8 drugs
| Paxlovid | 11 | $1,429 | $130 |
| Albuterol Sulfate Hfa | 14 | $468 | $33 |
| Levothyroxine | 25 | $332 | $13 |
| Losartan | 25 | $263 | $11 |
| Atorvastatin | 16 | $250 | $16 |
| Metoprolol | 19 | $193 | $10 |
| Amlodipine Besylate | 22 | $130 | $6 |
| Montelukast | 12 | $112 | $9 |
Year by year
| 2024 | 444 | 164 | None | None | $29,132 |
| 2023 | 1,470 | 344 | None | None | $77,652 |
| 2022 | 1,002 | 224 | None | None | $41,289 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 38 drugs
| Albuterol Sulfate Hfa | 50 | $1,502 | $30 |
| Diclofenac | 41 | $908 | $22 |
| Oseltamivir Phosphate | 23 | $905 | $39 |
| Triamcinolone Acetonide | 20 | $831 | $42 |
| Nitrofurantoin Mono-Macro | 34 | $712 | $21 |
| Losartan | 46 | $705 | $15 |
| Rosuvastatin | 31 | $665 | $21 |
| Levothyroxine | 26 | $534 | $21 |
| Lactulose | 16 | $519 | $32 |
| Metoprolol | 22 | $478 | $22 |
| Montelukast | 20 | $473 | $24 |
| Azithromycin | 82 | $468 | $6 |
| Atorvastatin | 35 | $459 | $13 |
| Baclofen | 44 | $434 | $10 |
| Cephalexin | 45 | $421 | $9 |
| Clotrimazole-Betamethasone | 11 | $410 | $37 |
| Omeprazole | 25 | $404 | $16 |
| Gabapentin | 35 | $395 | $11 |
| Tamsulosin | 16 | $391 | $24 |
| Metformin | 34 | $377 | $11 |
| Amlodipine Besylate | 41 | $369 | $9 |
| Ondansetron Odt | 14 | $355 | $25 |
| Celecoxib | 16 | $349 | $22 |
| Simvastatin | 20 | $324 | $16 |
| Trazodone | 24 | $283 | $12 |
| Fluticasone Propionate | 20 | $272 | $14 |
| Hydrochlorothiazide | 19 | $265 | $14 |
| Mupirocin | 15 | $240 | $16 |
| Ibuprofen | 50 | $239 | $5 |
| Ciprofloxacin | 20 | $229 | $11 |
| Meloxicam | 22 | $202 | $9 |
| Amoxicillin-Clavulanate Potass | 18 | $198 | $11 |
| Glimepiride | 15 | $198 | $13 |
| Fluconazole | 17 | $169 | $10 |
| Promethazine-Dm | 13 | $159 | $12 |
| Lisinopril | 12 | $149 | $12 |
| Amoxicillin | 18 | $78 | $4 |
| Prednisone | 23 | $54 | $2 |
2022: 26 drugs
| Albuterol Sulfate Hfa | 44 | $1,523 | $35 |
| Diclofenac | 31 | $689 | $22 |
| Simvastatin | 29 | $584 | $20 |
| Rosuvastatin | 17 | $542 | $32 |
| Baclofen | 24 | $531 | $22 |
| Oseltamivir Phosphate | 11 | $530 | $48 |
| Metoprolol | 27 | $512 | $19 |
| Levothyroxine | 22 | $445 | $20 |
| Losartan | 40 | $445 | $11 |
| Atorvastatin | 37 | $442 | $12 |
| Nitrofurantoin Mono-Macro | 16 | $419 | $26 |
| Montelukast | 18 | $379 | $21 |
| Gabapentin | 25 | $345 | $14 |
| Metformin | 28 | $320 | $11 |
| Amlodipine Besylate | 32 | $288 | $9 |
| Lisinopril | 18 | $276 | $15 |
| Azithromycin | 38 | $240 | $6 |
| Amoxicillin-Clavulanate Potass | 15 | $209 | $14 |
| Hydrochlorothiazide | 25 | $203 | $8 |
| Cephalexin | 22 | $181 | $8 |
| Glimepiride | 14 | $150 | $11 |
| Ibuprofen | 26 | $129 | $5 |
| Omeprazole | 11 | $105 | $10 |
| Amoxicillin | 14 | $76 | $5 |
| Ciprofloxacin | 12 | $54 | $4 |
| Prednisone | 13 | $47 | $4 |
Money from drug and device companies
$47 in 2023
| 2023 | 1 | 2 | None | $47 |
| 2022 | 1 | 1 | None | $35 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| GlaxoSmithKline | Trelegy Ellipta | $47 | 2 payments
|
See all 2 published payments
| GlaxoSmithKline | Meals · 2023-10-04 | Trelegy Ellipta | $25 |
| GlaxoSmithKline | Meals · 2023-04-05 | Trelegy Ellipta | $22 |
See earlier years (2022)
2022: $35
| GlaxoSmithKline | Trelegy Ellipta | $35 | 1 payment
|
Professional record
- NPI
- 1396401071
- Licence
- CA NP95019082
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 363LF0000X (363LF0000X)
- Mailing address
- 325 Distel Cir, Los Altos, CA, 94022
- NPI first listed
- 2021-11-16
- NPI last updated
- 2024-03-06
- NPI record certified
- 2024-03-06
This is when the NPI record was last certified, not a medical board exam.